Prem S Shah Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 weeks, 3 days ago
Prem S Shah has an estimated net worth of at least $10.1 million*, as of Oct. 29, 2025. They own 60,631 shares of CVS stock. They have sold 56,397 shares of CVS stock since 2021, for an estimated $5.1 million.
Prem S Shah $CVS SEC Form 4 Insider Trading
Prem S Shah has filed a total of 9 insider trades in $CVS since 2021. Their most recent trade was a sale of 29,473 shares, made on Feb 16, 2024. Their largest trade was a sale of 29,473 shares, made on Feb 16, 2024. We estimate that they now own 60,631 shares of $CVS, worth an estimated $5.0 million.
Insider Trading at $CVS
There have been a total of 54 insider trades reported at $CVS since 2021, with 61,831 shares purchased and 4.8 million shares sold. The most active insider traders in $CVS stock have been Prem S Shah, Daniel P Finke, and Alan Lotvin. The most recent trade was a purchase of 35 shares reported by HEIDI B CAPOZZI (EVP and Chief People Officer), made on Oct 23, 2024.
History of Insider Stock Trades by Prem S Shah
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CVS
|
Sale | 29,473 | Feb 16, 2024 | Feb. 16, 2024, 7:46 p.m. |
|
CVS
|
Sale | 845 | Apr 08, 2022 | April 12, 2022, 4:51 p.m. |
|
CVS
|
Sale | 3,157 | Apr 08, 2022 | April 12, 2022, 4:51 p.m. |
|
CVS
|
Sale | 5,719 | Apr 08, 2022 | April 12, 2022, 4:51 p.m. |
|
CVS
|
Sale | 4,103 | Apr 08, 2022 | April 12, 2022, 4:51 p.m. |
|
CVS
|
Sale | 3,130 | Apr 08, 2022 | April 12, 2022, 4:51 p.m. |
|
CVS
|
Sale | 5,346 | Mar 30, 2022 | March 30, 2022, 8 p.m. |
|
CVS
|
Sale | 2,935 | Mar 17, 2022 | March 18, 2022, 4:55 p.m. |
|
CVS
|
Sale | 1,689 | Mar 17, 2022 | March 18, 2022, 4:55 p.m. |
$CVS Executives and Stock Owners with Insider Trades
-
Prem S Shah, EVP and Co-President of Retail
-
Daniel P Finke, EVP/Pres, Health Care Benefits
-
Alan Lotvin, EVP&President-PharmacyServices
-
Thomas M Moriarty, EVP & General Counsel
-
Troyen A Brennan, EVP and Chief Medical Officer
-
James David Clark, SVP, Cont & Chief Acct Officer
-
Heidi B Capozzi, EVP and Chief People Officer
-
Jonathan C Roberts, EVP & Chief Operating Officer
-
Karen S Lynch, President and CEO
-
Prem S Shah, EVP and Pres-Pharm, Consumer W
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.